Search clinical trials for: ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol)
Total 62 results
-
Polaris GroupCompletedNon-Hodgkin's LymphomaTaiwan
-
Polaris GroupCompleted
-
University of MiamiCompletedMelanoma (Skin)United States
-
Polaris GroupCompletedCutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid TumorsTaiwan, United States
-
Polaris GroupCompletedHepatocellular CarcinomaUnited States
-
Polaris GroupCompletedHepatocellular CarcinomaUnited States, Korea, Republic of, Taiwan, Italy, United Kingdom, China
-
Polaris GroupCompletedUnresectable Hepatocellular CarcinomaTaiwan
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; National Taiwan University Hospital; Duke... and other collaboratorsTerminatedSmall Cell Lung CancerUnited States, Taiwan, Germany, Belgium, United Kingdom
-
Polaris GroupCompletedArgininosuccinate Synthetase DeficientUnited States
-
Polaris GroupCompletedProstate Cancer | Solid TumorsUnited States
-
Catholic University of the Sacred HeartCompletedColonic Polyps | Inflammatory Bowel Disease | Cancer ColonItaly
-
Washington University School of MedicinePolaris GroupRecruitingSmall Cell Lung Carcinoma | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Small-cell Lung CancerUnited States
-
Postgraduate Institute of Medical Education and...UnknownAcute-On-Chronic Liver Failure | Hepatic EncephalopathyIndia
-
Southern California Institute for Research and...UnknownBowel Preparation for ColonoscopyUnited States
-
Fundación Pública Andaluza para la gestión de la...Unknown
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
M.D. Anderson Cancer CenterWithdrawnResectable Hepatocellular CarcinomaUnited States
-
Indiana UniversityRecruiting
-
National Cancer Center, KoreaDaehang HospitalCompletedComparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel PreparationHealthyKorea, Republic of
-
Augusta UniversityTakeda Pharmaceuticals North America, Inc.TerminatedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
Children's Oncology GroupRecruitingLymphoblastic Lymphoma | B Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia, BCR-ABL1-LikeUnited States, Canada
-
Sichuan UniversityAffiliated Hospital of North Sichuan Medical College; Affiliated Hospital of...Completed
-
Changi General HospitalRecruiting
-
BayerRecruitingHemophilia A | Prophylaxis of BleedingUnited States
-
Azienda Policlinico Umberto IUnknown
-
M.D. Anderson Cancer CenterActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Tumor Lysis SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Not yet recruitingMetastatic Sarcoma | Resectable Sarcoma | Recurrent SarcomaUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedB-cell Adult Acute Lymphoblastic Leukemia (ALL) | Ph-positive Adult Acute Lymphoblastic Leukemia (ALL) | Recurrent Adult Acute Lymphoblastic Leukemia (ALL) | T-cell Adult Acute Lymphoblastic Leukemia (ALL)United States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic Leukemia | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Childhood Lymphoblastic Lymphoma | Childhood T Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedB-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | Intermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, Switzerland
-
National Cancer Institute (NCI)CompletedRecurrent Adult Lymphoblastic Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | B-cell Adult Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Australia, Canada, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI); University College, London; Medical Research...CompletedMetastatic Osteosarcoma | Localized OsteosarcomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
National Cancer Institute (NCI)CompletedT-cell Childhood Acute Lymphoblastic Leukemia | Untreated Childhood Acute Lymphoblastic LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic LymphomaUnited States, Puerto Rico
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia | Ph-Like Acute Lymphoblastic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand
-
National Cancer Institute (NCI)Not yet recruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic Lymphoma
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic LymphomaUnited States
-
National Cancer Institute (NCI)CompletedChildhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)Not yet recruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Down Syndrome | Philadelphia Chromosome Positive | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia | Adult B Lymphoblastic Lymphoma | Ann Arbor Stage I B Lymphoblastic Lymphoma | Ann Arbor Stage... and other conditionsUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada, Australia
-
National Cancer Institute (NCI)SuspendedDown Syndrome | Recurrent B Acute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Lymphoblastic Lymphoma | Mixed Phenotype Acute LeukemiaUnited States, Canada, Australia, Puerto Rico, New Zealand
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage